Cargando…

Hospice-Palliative Medicine as a Model of Value-Based Healthcare

Detalles Bibliográficos
Autores principales:	Heo, Dae Seog, Yoo, Shin Hye, Keam, Bhumsuk, Yoo, Keunjoo, Choi, Insun, Kim, Min-Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2022
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015901/ https://www.ncbi.nlm.nih.gov/pubmed/35437962 http://dx.doi.org/10.3346/jkms.2022.37.e111

Ejemplares similares

The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
por: Heo, Dae Seog, et al.
Publicado: (2022)

Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study
por: Yoo, Shin Hye, et al.
Publicado: (2021)

Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Challenges in Care for Non-COVID-19 Patients with Severe Chronic Illnesses during COVID-19 Pandemic: A Qualitative Study of Healthcare Providers Working around Acute Care Hospitals in South Korea
por: Kim, Yejin, et al.
Publicado: (2023)

Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
por: Kim, Jung Sun, et al.
Publicado: (2020)

Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life
por: Kim, Jung Sun, et al.
Publicado: (2023)

Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea
por: Kim, Jung Sun, et al.
Publicado: (2022)

Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
por: Ock, Chan-Young, et al.
Publicado: (2019)

The National Hospice and Palliative Care registry in Korea
por: Kim, Kyuwoong, et al.
Publicado: (2022)

Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute
por: Choi, Younak, et al.
Publicado: (2015)

Barriers to Counseling on Advance Directives Based on Counselors’ Experiences: Focus Group Interviews
por: Kim, Yejin, et al.
Publicado: (2020)

Moral Distress Regarding End-of-Life Care Among Healthcare Personnel in Korean University Hospitals: Features and Differences Between Physicians and Nurses
por: Choi, Eun Kyung, et al.
Publicado: (2023)

Integration of the Verbatim Exercise into a Hospice and Palliative Medicine Fellowship
por: Powers, Christopher R., et al.
Publicado: (2023)

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors
por: Kim, Hyungjin, et al.
Publicado: (2017)

Impact of COVID-19 on the End-of-Life Care of Cancer Patients Who Died in a Korean Tertiary Hospital: A Retrospective Study
por: Shin, Jeongmi, et al.
Publicado: (2022)

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: Oh, So Yeon, et al.
Publicado: (2021)

The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
por: Choi, Ji Young, et al.
Publicado: (2019)

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
por: Cho, Kyoung Min, et al.
Publicado: (2015)

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients
por: Heo, Ja Yoon, et al.
Publicado: (2021)

The Impact of Virtual Interviews on Recruitment in Hospice and Palliative Medicine Fellowship Training
por: Sands, Rebecca, et al.
Publicado: (2022)

Ethical Issues Referred to Clinical Ethics Support at a University Hospital in Korea: Three-Year Experience After Enforcement of Life-Sustaining Treatment Decisions Act
por: Yoo, Shin Hye, et al.
Publicado: (2023)

The Island Hospice model of palliative care
por: Khumalo, Thembelihle, et al.
Publicado: (2016)

Changes in the Utilization of Health Care Services by Cancer Patients during the COVID-19 Pandemic
por: Seo, Seung Hee, et al.
Publicado: (2023)

Development and Evaluation of a Hospice and Palliative Care Music Therapy Education Program
por: Kim, Eun Jung, et al.
Publicado: (2020)

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
por: Yoo, Shin Hye, et al.
Publicado: (2019)

Healthcare-associated Infection Control on the Edge of a ‘Carrot-and-Stick’ and a ‘Crime-and-Punishment’ Frame
por: Yoo, Jin-Hong
Publicado: (2018)

The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Kim, Ryul, et al.
Publicado: (2016)

The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis
por: Kim, Jae Sik, et al.
Publicado: (2019)

China's current situation and development of hospice and palliative care in critical care medicine
por: Su, Longxiang, et al.
Publicado: (2023)

The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines
por: Lee, Jeongjae, et al.
Publicado: (2022)

Lessons in Stories: Why Narrative Medicine Has a Role in Pediatric Palliative Care Training
por: Lanocha, Natalie
Publicado: (2021)

Hospice and Palliative Care in China: Development and Challenges
por: Lu, Yuhan, et al.
Publicado: (2018)

The Use of Antibiotics in Hospice and Palliative Care Settings
por: C. Shekhar, Aditya
Publicado: (2022)

Practical Considerations in Providing End-of-Life Care for Dying Patients and Their Family in the Era of COVID-19
por: Kim, Yejin, et al.
Publicado: (2021)

Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib
por: Kim, Seulki, et al.
Publicado: (2019)

Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
por: Kim, Miso, et al.
Publicado: (2023)

The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer
por: Lee, June-Koo, et al.
Publicado: (2015)

Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
por: Kim, Miso, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_outhhknjj8cuvdj6qs1aqsfc98